On October 29, 2019, Medidata and CR Medicon will join hands and invite you to participate in the “Clinical Development Strategy and Trial Design Workshop” in Suzhou, China. Let’s explore opportunities and challenges in the field of clinical research, through a zero-distance discussion with experts together with in-depth and live demonstrations.
Drug clinical trials are the longest and most costly stages of drug development and face many uncertainties. Developments in digital technology in drug development can significantly reduce the cost of drug development, accelerate the time-to-market, and bring more hope to patients. In this partnership, Medidata has the world’s most commonly used clinical development, commercial data and real-world data platform; whereas leading the digital transformation in life sciences, CR Medicon’s expert team with extensive experience in clinical development services work to minimize your risk and optimize your results.
About CR Medicon CR Medicon provides a full range of clinical development services, including drug and equipment registration, medical affairs, clinical operations, biological sample analysis, drug alert, data management and statistical analysis, of which the eCTD system is an integral part of our one-stop clinical CRO services. Since our founding in 2017, CR Medicon has become the clinical CRO partners for nearly a hundred well-known domestic and foreign biotech and pharmaceutical enterprises. CR Medicon team brings together the industry’s experts, has extensive experience in phase I-III new drug clinical, medical device and BE trials. and has been involved in clinical trial monitoring and project management in cutting-edge areas.